ARGS
$0.17
Argos Therapeutics
($.03)
(15.00%)
ARGS
Earnings Whisper ®
N/A
3rd Quarter September 2017
Consensus:  $0.00
Revenue:  $0.10 Mil
Wednesday
Nov 8
Before the open
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when ARGS reports earnings?
Beat
Meet
Miss

Where is ARGS's stock price going from here?
Up
Flat
Down
Stock chart of ARGS
Analysts
Summary of analysts' recommendations for ARGS
Score
Grade
Pivots
Resistance
$0.23
$0.22
$0.21

$0.20

Support
$0.19
$0.18
$0.17
Tweet
Growth
Peers
Regeneron PharmaceuticalsBioMarin PharmaceuticalCelgeneVertex PharmaceuticalsEli LillyUltragenyx PharmaceuticalZoetisInterCeptJohnson & JohnsonPfizer